Opthea Ltd Files 6-K Report
Ticker: OPTEY · Form: 6-K · Filed: Nov 20, 2025 · CIK: 1815620
Sentiment: neutral
Topics: regulatory-filing, press-release, biotechnology
TL;DR
Opthea Ltd filed a 6-K on Nov 20, 2025, with a press release attached. Check for updates.
AI Summary
Opthea Limited filed a Form 6-K on November 20, 2025, reporting information for the month of November 2025. The filing includes a press release dated November 20, 2025, as Exhibit 99.1. Opthea Limited is a biotechnology company focused on biological products.
Why It Matters
This filing provides an update from Opthea Limited, which could contain important information for investors regarding the company's operations or strategic developments.
Risk Assessment
Risk Level: low — This is a routine filing (6-K) that primarily serves to submit a press release and does not appear to contain significant new financial or operational disclosures.
Key Players & Entities
- Opthea Limited (company) — Registrant
- November 20, 2025 (date) — Filing Date and Press Release Date
- 001-39621 (other) — SEC File Number
FAQ
What is the purpose of a Form 6-K filing?
A Form 6-K is filed by foreign private issuers to report information that they have made or are required to make public in their home country, or that they have distributed or are required to distribute to their security holders.
What is the primary exhibit included in this 6-K filing?
The primary exhibit included is Exhibit 99.1, which is a press release dated November 20, 2025.
What is Opthea Limited's Standard Industrial Classification (SIC) code?
Opthea Limited's SIC code is 2836, which corresponds to Biological Products (No Diagnostic Substances).
Where is Opthea Limited's principal executive office located?
Opthea Limited's principal executive office is located in Australia, with the filing address listed as C/- Prime Company Compliance, Level 9, 505 Little Collins Street, Melbourne, VIC 3000.
Does Opthea Limited file annual reports under Form 20-F or Form 40-F?
Opthea Limited indicates that it files annual reports under Form 20-F.
Filing Stats: 151 words · 1 min read · ~1 pages · Grade level 13.3 · Accepted 2025-11-20 16:02:11
Filing Documents
- d79192d6k.htm (6-K) — 8KB
- d79192dex991.htm (EX-99.1) — 6KB
- g79192g1120080629685.jpg (GRAPHIC) — 3KB
- 0001193125-25-289730.txt ( ) — 20KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereto duly authorized. OPTHEA LIMITED (Registrant) By: /s/ Jeremy Levin Name: Jeremy Levin Title: Chief Executive Officer Date: November 20, 2025